Hayakawa Morisada, Sakashita Eiji, Ueno Eriko, Tominaga Shin-ichi, Hamamoto Toshiro, Kagawa Yasuo, Endo Hitoshi
Department of Biochemistry, Jichi Medical School, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan.
J Biol Chem. 2002 Mar 1;277(9):6974-84. doi: 10.1074/jbc.M110138200. Epub 2001 Dec 13.
Mitochondrial ATP synthase gamma-subunit (F(1)gamma) pre-mRNA undergoes alternative splicing in a tissue- or cell type-specific manner. Exon 9 of F(1)gamma pre-mRNA is specifically excluded in heart and skeletal muscle tissues and in acid-stimulated human fibrosarcoma HT1080 cells, rhabdomyosarcoma KYM-1 cells, and mouse myoblast C2C12 cells. Recently, we found a purine-rich exonic splicing enhancer (ESE) element on exon 9 via transgenic mice bearing F(1)gamma mutant minigenes and demonstrated that this ESE functions ubiquitously with exception of muscle tissue (Ichida, M., Hakamata, Y., Hayakawa, M., Ueno E., Ikeda, U., Shimada, K., Hamamoto, T., Kagawa, Y., Endo, H. (2000) J. Biol. Chem. 275, 15992-16001). Here, we identified an exonic negative regulatory element responsible for muscle-specific exclusion of exon 9 using both in vitro and in vivo splicing systems. A supplementation assay with nuclear extracts from HeLa cells and acid-stimulated HT1080 cells was performed for an in vitro reaction of muscle-specific alternative splicing of F(1)gamma minigene and revealed that the splicing reaction between exons 8 and 9 was the key step for regulation of muscle-specific exon exclusion. Polypyrimidine tract in intron 8 requires ESE on exon 9 for constitutive splice site selection. Mutation analyses on the F(1)gammaEx8-9 minigene using a supplementation assay demonstrated that the muscle-specific negative regulatory element is positioned in the middle region of exon 9, immediately downstream from ESE. Detailed mutation analyses identified seven nucleotides (5'-AGUUCCA-3') as a negative regulatory element responsible for muscle-specific exon exclusion. This element was shown to cause exon skipping in in vivo splicing systems using acid-stimulated HT1080 cells after transient transfection of several mutant F(1)gammaEx8-9-10 minigenes. These results demonstrated that the 5'-AGUUCCA-3' immediately downstream from ESE is a muscle-specific exonic splicing silencer (MS-ESS) responsible for exclusion of exon 9 in vivo and in vitro.
线粒体ATP合酶γ亚基(F(1)γ)前体mRNA以组织或细胞类型特异性方式进行可变剪接。F(1)γ前体mRNA的外显子9在心脏和骨骼肌组织以及酸刺激的人纤维肉瘤HT1080细胞、横纹肌肉瘤KYM-1细胞和小鼠成肌细胞C2C12细胞中被特异性排除。最近,我们通过携带F(1)γ突变小基因的转基因小鼠在外显子9上发现了一个富含嘌呤的外显子剪接增强子(ESE)元件,并证明该ESE除肌肉组织外普遍发挥作用(市田真、滨又洋、早川真、上野惠、池田悠、岛田健、滨本拓、香川洋、远藤浩(2000年)《生物化学杂志》275卷,第15992 - 16001页)。在此,我们使用体外和体内剪接系统鉴定了一个负责外显子9肌肉特异性排除的外显子负调控元件。对F(1)γ小基因肌肉特异性可变剪接的体外反应进行了用HeLa细胞和酸刺激的HT1080细胞核提取物的补充试验,结果表明外显子8和9之间的剪接反应是调控肌肉特异性外显子排除的关键步骤。内含子8中的多嘧啶序列需要外显子9上的ESE来进行组成型剪接位点选择。使用补充试验对F(1)γEx8 - 9小基因进行的突变分析表明,肌肉特异性负调控元件位于外显子9的中间区域,紧接在ESE下游。详细的突变分析确定了七个核苷酸(5'-AGUUCCA-3')作为负责肌肉特异性外显子排除的负调控元件。在瞬时转染几个突变F(1)γEx8 - 9 - 10小基因后,使用酸刺激的HT1080细胞的体内剪接系统显示该元件会导致外显子跳跃。这些结果表明,紧接在ESE下游的5'-AGUUCCA-3'是一个肌肉特异性外显子剪接沉默子(MS-ESS),负责在体内和体外排除外显子9。